scispace - formally typeset
D

Daniel W. Chan

Researcher at Hong Kong Polytechnic University

Publications -  707
Citations -  47988

Daniel W. Chan is an academic researcher from Hong Kong Polytechnic University. The author has contributed to research in topics: Cancer & Prostate cancer. The author has an hindex of 106, co-authored 663 publications receiving 41915 citations. Previous affiliations of Daniel W. Chan include Merck & Co. & Charité.

Papers
More filters
Journal ArticleDOI

Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database.

TL;DR: Reverse protein to DNA matching identified proteins for 118 previously unidentified ORFs in the PPP database, and the database permits examination of many other subsets, such as 1274 proteins identified with three or more peptides.
Journal ArticleDOI

A comparative study of causes of time overruns in Hong Kong construction projects

TL;DR: In this paper, the authors present the results of a survey undertaken to determine and evaluate the relative importance of the significant factors causing delays in Hong Kong construction projects, including poor site management and supervision, unforeseen ground conditions, low speed of decision making involving all project teams, client-initiated variations and necessary variations of works.
Journal ArticleDOI

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer

TL;DR: A view of how the somatic genome drives the cancer proteome and associations between protein and post-translational modification levels and clinical outcomes in HGSC is provided.
Journal ArticleDOI

Immunosensors--principles and applications to clinical chemistry.

TL;DR: Clinical chemists should take advantage of immunosensors in clinical diagnostics as the future role of this technique in intralaboratory, as well as bedside testing, will become even more important as the clinical laboratory is faced with increasing pressure to contain costs.